Merrimack Pharmaceuticals, Inc. EBITDA 2010-2024 | MACK

Merrimack Pharmaceuticals, Inc. ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Merrimack Pharmaceuticals, Inc. Annual EBITDA
(Millions of US $)
2023 $-2
2022 $-2
2021 $-2
2020 $-3
2019 $-20
2018 $-62
2017 $-91
2016 $-142
2015 $-142
2014 $-63
2013 $-118
2012 $-89
2011 $-76
2010 $-46
2009 $-45
Merrimack Pharmaceuticals, Inc. Quarterly EBITDA
(Millions of US $)
2024-03-31 $-1
2023-12-31 $-0
2023-09-30 $-1
2023-06-30 $-1
2023-03-31 $-0
2022-12-31 $-1
2022-09-30 $-1
2022-06-30 $-0
2022-03-31 $-0
2021-12-31 $-0
2021-09-30 $-1
2021-06-30 $-1
2021-03-31 $-1
2020-12-31 $-1
2020-09-30 $-1
2020-06-30 $-1
2020-03-31 $0
2019-12-31 $-2
2019-09-30 $-1
2019-06-30 $-8
2019-03-31 $-9
2018-12-31 $-14
2018-09-30 $-16
2018-06-30 $-16
2018-03-31 $-16
2017-12-31 $-15
2017-09-30 $-16
2017-06-30 $-34
2017-03-31 $-26
2016-12-31 $-41
2016-09-30 $-34
2016-06-30 $-35
2016-03-31 $-33
2015-12-31 $9
2015-09-30 $-36
2015-06-30 $-18
2015-03-31 $-29
2014-12-31 $-5
2014-09-30 $-23
2014-06-30 $-13
2014-03-31 $-23
2013-12-31 $-28
2013-09-30 $-35
2013-06-30 $-28
2013-03-31 $-27
2012-12-31 $-24
2012-09-30 $-23
2012-06-30 $-19
2012-03-31 $-23
2011-12-31 $-17
2011-09-30 $-17
2011-06-30 $-28
2011-03-31 $-13
2010-12-31 $6
2010-09-30 $6
2010-06-30 $4
2010-03-31 $4
2009-12-31